K

Knoxville Kidney Center | Knoxville, TN

Research site
(Unclaimed)
Location
320 Park 40 North Boulevard, Suite A, Knoxville, Tennessee, United States of America
Site insights

Top conditions

Kidney Diseases (5 trials)

Chronic Renal Insufficiency (3 trials)

Diabetic Nephropathies (1 trial)

Polycystic Kidney Diseases (1 trial)

Diabetes Mellitus (1 trial)

Top treatments

Selonsertib
EYE103
SNF472
GS-4997
Lixivaptan
PRT-201
NOV-001
apixaban
Finerenone
warfarin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 10
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) (AMARONE)

EYE103-101 is a 2-part study assessing safety and preliminary efficacy of EYE103 in patients with diabetic macular edema (DME) given as monotherapy o...

Enrolling
Diabetic Macular Edema (DME)
Neovascular Age-related Macular Degeneration (NVAMD)
Drug: EYE103

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Active, not recruiting
Chronic Kidney Diseases
Type 2 Diabetes Mellitus
Biological: Renal Autologous Cell Therapy (REACT)

Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finere...

Active, not recruiting
Non-diabetic Chronic Kidney Disease
Drug: Finerenone (BAY94-8862)
Drug: Placebo

Trial sponsors

Bayer logo

Bayer (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems